Chiang, Shu JenShu JenChiangTseng, Po HangPo HangTsengMEI-CHUN LINLeu, Chih YuChih YuLeuCHEN-YUAN DONGPEI-JEN LOU2024-03-042024-03-042023-09-0127729060https://scholars.lib.ntu.edu.tw/handle/123456789/640186• Demonstrate patient tumor slice organoid (PTSO) as an in vitro rapid platform in identifying cisplatin-resistant patients. • Water soluble tetrazolium salt (WST-8) assay was used a viability test for determining cisplatin-resistance. • Cisplatin-resistance data obtained within 5 days after the initiation of PTSO culture. • Report cisplatin-resistance of a male 43 years with recurrent tongue cancer as validated from the patient's survival periods.Chemotherapy | Cisplatin resistance | Head and neck squamous cell carcinoma | Patient tumor slice organoid | Rapid drug susceptibility screening platform | Tetrazolium salt assay[SDGs]SDG3other10.1016/j.oor.2023.1000532-s2.0-85180714249https://api.elsevier.com/content/abstract/scopus_id/85180714249